Tuzmen S - Search Results

1

Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer.

Huusko P, Ponciano-Jackson D, Wolf M, Kiefer JA, Azorsa DO, Tuzmen S, Weaver D, Robbins C, Moses T, Allinen M, Hautaniemi S, Chen Y, Elkahloun A, Basik M, Bova GS, Bubendorf L, Lugli A, Sauter G, Schleutker J, Ozcelik H, Elowe S, Pawson T, Trent JM, Carpten JD, Kallioniemi OP, Mousses S. Huusko P, et al. Among authors: tuzmen s. Nat Genet. 2004 Sep;36(9):979-83. doi: 10.1038/ng1408. Epub 2004 Aug 8. Nat Genet. 2004. PMID: 15300251

2

Validation of short interfering RNA knockdowns by quantitative real-time PCR.

Tuzmen S, Kiefer J, Mousses S. Tuzmen S, et al. Methods Mol Biol. 2007;353:177-203. doi: 10.1385/1-59745-229-7:177. Methods Mol Biol. 2007. PMID: 17332642

3

Functional evidence implicating S100P in prostate cancer progression.

Basu GD, Azorsa DO, Kiefer JA, Rojas AM, Tuzmen S, Barrett MT, Trent JM, Kallioniemi O, Mousses S. Basu GD, et al. Among authors: tuzmen s. Int J Cancer. 2008 Jul 15;123(2):330-339. doi: 10.1002/ijc.23447. Int J Cancer. 2008. PMID: 18452169

4

Intersex-like (IXL) is a cell survival regulator in pancreatic cancer with 19q13 amplification.

Kuuselo R, Savinainen K, Azorsa DO, Basu GD, Karhu R, Tuzmen S, Mousses S, Kallioniemi A. Kuuselo R, et al. Among authors: tuzmen s. Cancer Res. 2007 Mar 1;67(5):1943-9. doi: 10.1158/0008-5472.CAN-06-3387. Cancer Res. 2007. PMID: 17332321

5

An integrated genomic approach identifies ARID1A as a candidate tumor-suppressor gene in breast cancer.

Mamo A, Cavallone L, Tuzmen S, Chabot C, Ferrario C, Hassan S, Edgren H, Kallioniemi O, Aleynikova O, Przybytkowski E, Malcolm K, Mousses S, Tonin PN, Basik M. Mamo A, et al. Among authors: tuzmen s. Oncogene. 2012 Apr 19;31(16):2090-100. doi: 10.1038/onc.2011.386. Epub 2011 Sep 5. Oncogene. 2012. PMID: 21892209

6

Human SNPs resulting in premature stop codons and protein truncation.

Savas S, Tuzmen S, Ozcelik H. Savas S, et al. Among authors: tuzmen s. Hum Genomics. 2006 Mar;2(5):274-86. doi: 10.1186/1479-7364-2-5-274. Hum Genomics. 2006. PMID: 16595072 Free PMC article.

7

RNAi-based functional pharmacogenomics.

Tuzmen S, Tuzmen P, Arora S, Mousses S, Azorsa D. Tuzmen S, et al. Among authors: tuzmen p. Methods Mol Biol. 2011;700:271-90. doi: 10.1007/978-1-61737-954-3_18. Methods Mol Biol. 2011. PMID: 21204040

8

Characterization of farnesyl diphosphate farnesyl transferase 1 (FDFT1) expression in cancer.

Tüzmen Ş, Hostetter G, Watanabe A, Ekmekçi C, Carrigan PE, Shechter I, Kallioniemi O, Miller LJ, Mousses S. Tüzmen Ş, et al. Per Med. 2019 Jan;16(1):51-65. doi: 10.2217/pme-2016-0058. Epub 2018 Nov 23. Per Med. 2019. PMID: 30468409

9

Discovery of genetic profiles impacting response to chemotherapy: application to gemcitabine.

Jarjanazi H, Kiefer J, Savas S, Briollais L, Tuzmen S, Pabalan N, Ibrahim-Zada I, Mousses S, Ozcelik H. Jarjanazi H, et al. Among authors: tuzmen s. Hum Mutat. 2008 Apr;29(4):461-7. doi: 10.1002/humu.20732. Hum Mutat. 2008. PMID: 18330920

10

NCI60 cancer cell line panel data and RNAi analysis help identify EAF2 as a modulator of simvastatin and lovastatin response in HCT-116 cells.

Savas S, Azorsa DO, Jarjanazi H, Ibrahim-Zada I, Gonzales IM, Arora S, Henderson MC, Choi YH, Briollais L, Ozcelik H, Tuzmen S. Savas S, et al. Among authors: tuzmen s. PLoS One. 2011 Apr 4;6(4):e18306. doi: 10.1371/journal.pone.0018306. PLoS One. 2011. PMID: 21483694 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters